
The PPSV Resource Center provides white papers, speeches, published articles, and external links. No representation is made about the validity or usefulness of the external links. If we can assist you or answer any questions you might have, please call us in Washington, DC at 202.466.6550, or send us an email.
Jurisdictional Issues Related to PRRB Appeals
Barbara Straub Williams
Healthcare Financial Management, the journal of the Healthcare Financial Management Association, May 2006
Baystate Medical Center v. Mutual of Omaha Ins. Co.
Recent PRRB decision on calculation of DSH Medicare/SSI fraction
PRRB Dec. No. 2006-D20, March 2006
Manufacturer Patient Assistance Programs -- Inside or Outside Part D?
Mark Fitgerald
BNA’s Medicare Report, Vol. 17, No. 03, January 2006
OIG Clears a Path for Manufacturer Patient Assistance Programs
Mark Fitzgerald
December 2005
Fraud and Abuse Update (09/05)
Mark Fitzgerald & Barbara Straub Williams
September 2005
Summary of Baystate Hospital System v. Leavitt
Barbara Straub Williams & Mary Susan Philp
July 2005
Counter Intelligence?
Barbara Straub Williams
Healthcare Financial Management, July 2005
CMS Proposes New Conditions of Participation for Transplant Centers
Rebecca L. Burke
Health Lawyers Weekly, May 13, 2005
Proposed Changes to Medicare Hospital Inpatient Prospective Payment System ("PPS") for Federal Fiscal Year 2006
Barbara Straub Williams
May 2005
Federal Drug Discount and Compliance Monitor, Volume 1, No. 1
(PDF version, 574 KB), July 2004
Office of Inspector General Advisory Opinion 04-08 - Physician Ownership of Physical Therapy Center
July 2004
Glossary of Drug Pricing and Other Pharmaceutical Terms (2007 Update)
May 2004
Glossary of drug pricing terminology with an emphasis on the Public Health Service's 340B drug discount program
Stark II Phase II -- Implications for Physicians and Groups
April 19, 2004
HHS OIG Targeting Organ Transplant Services in 2004
Rebecca L. Burke
BNA (PDF version, 87 KB), January 30, 2004
PPSV Provides Audio Conference on New Medicare Legislation (online copy of presentation)
December 15, 2003
Final Conference Language of Medicare Reform Bill (Updated Nov. 21, 2003)
(PDF version, 1.48 MB), November 21, 2003
New Process for Seeking Medicare National Coverage Determinations | (PDF version, 114 KB)
Rebecca L. Burke
October 16, 2003
Side-By-Side Analyses of House and Senate Medicare and Medicaid Bills of July 2003, by Congressional Research Service:
July 10, 2003
OIG's Compliance Program Guidance for Pharmaceutical Manufacturers
Rebecca L. Burke and Robert J. Saner II
May 2003
Analysis of Inspector Generals compliance guidance for the pharmaceutical industry
PPSV Plays Important Role in Nation's Largest Medicaid Fraud Settlement
April 2003
Article on recent Department of Justice settlements with pharmaceutical companies regarding drug pricing
Hospital Outlier Payment Issues and Current Investigations
Mark R. Fitzgerald
March 19, 2003
Outline from audioconference conducted by American Health Lawyers Association
Financial Support Arrangements Between Academic Medical Centers And Faculty Practice Plans
Mark R. Fitzgerald
March 2003
Analysis of arrangements between academic medical centers and tax-exempt faculty plans that employ their medical staff, including the implications of the Stark and Anti-Kickback laws
Glossary of Drug Pricing and Other Pharmaceutical Terms
September 2002
Glossary of drug pricing terminology with an emphasis on the Public Health Service's 340B drug discount program
Congress Increases TRICARE Program's Coverage of Assistive Technology
Peter W. Thomas
January 14, 2002
An Analysis of the legislative changes to the TRICARE program included in the Defense Reauthorization Act of 2001
OIG Open Letter to Health Care Providers: Corporate Integrity Agreements
Robert J. Saner II and Anthony Russo
December 2001
A description of the Office of Inspector General's policy announcement regarding the future use of corporate integrety agreements
OIG Special Advisory Bulletin: Practices of Business Consultants
Robert J. Saner II and Anthony Russo
July 11, 2001
A notice regarding the Office of Inspector General's policy announcement regarding the use of business consultants in the Medicare program
Johnson & Stark Issue Recommendations for Improvement of Medicare Program
Diane S. Millman and David O. Ault
May 18, 2001
A summary of the recommendations of Nancy Johnson and Pete Stark to Tommy Thompson for improvement of the Medicare program
Pharmaceutical Discounts Under Federal Law: State Program Opportunities
William von Oehsen
May 2001
Analysis of opportunities for state health programs to receive pharmaceuticals at a discounted price
Significant Features of Medical Information Privacy Regulations
James C. Pyles, Esq.
March 5, 2001
An outline of the HIPAA regulations governing medical information privacy
Summary of Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (adobe acrobat format)
Peter W. Thomas, Esq. & Jeremy Allen
January 19, 2001
Detailed summary of the Medicare Giveback legislation
The Stark II Regulations
Robert J. Saner II, Esq., Rebecca Burke, Esq., Marla Spindel, Esq., & Anthony Russo, Esq.
January 19, 2001
Analysis of the Stark II prohibition on physician self-referrals
Making a Voluntary Disclosure in Order to Avoid a Corporate Integrity Agreement: Is It Worth the Risk?
Harold Damelin and C. Anthony Russo
Analysis of the merits and risks of making a voluntary disclosure to the Office of Inspector General
Government Agencies & Services
Miscellaneous Healthcare Links
View Current Items in Resource Center >